Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment
Emerging and re-emerging viral diseases poses a threat to living organisms, and led to serious concern to humankind and public health. The last two decades, viral epidemics such as the severe acute respiratory syndrome(SARS-CoV) reported in the years 2002–2003, and H1N1 influenza (Swine flu) in 2009...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2020-09-01
|
Series: | AIMS Microbiology |
Subjects: | |
Online Access: | https://www.aimspress.com/article/10.3934/microbiol.2020013/fulltext.html |
id |
doaj-8b5eff0111e540049428df3fc407c759 |
---|---|
record_format |
Article |
spelling |
doaj-8b5eff0111e540049428df3fc407c7592020-11-25T03:40:39ZengAIMS PressAIMS Microbiology2471-18882020-09-016318320310.3934/microbiol.2020013Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatmentDharmender Kumar0Lalit Batra1Mohammad Tariq Malik21 Department of Biotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Murthal-131039, Sonepat, Haryana India2 Institute for Cellular Therapeutics,Departments of Microbiology and Immunology, University of Louisville, Louisville, Kentucky-40202, USA2 Institute for Cellular Therapeutics,Departments of Microbiology and Immunology, University of Louisville, Louisville, Kentucky-40202, USA 3 Departments of Microbiology and Immunology, Regenerative Medicine and Stem Cell Biology.and James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky-40202, USAEmerging and re-emerging viral diseases poses a threat to living organisms, and led to serious concern to humankind and public health. The last two decades, viral epidemics such as the severe acute respiratory syndrome(SARS-CoV) reported in the years 2002–2003, and H1N1 influenza (Swine flu) in 2009, middle east respiratory syndrome (MERS-CoV) from Saudi Arabia in 2012, Ebola virus in 2014–2016, and Zika virus in 2015. The recent outbreak of 2019-CoV-2 or severe acute respiratory syndrome-2(SARS-CoV-2), novel coronavirus (2019-nCoV, or 2019 disease, COVID-19) in Dec 2019, from, Wuhan city of China, has severe implications of health concerns to the whole world, due to global spread and high health risk. More than 423349 deaths had occurred globally and is still increasing every day. The whole world is under a health emergency, and people are advised to stay at their homes to avoid the spread of person-to-person infection, and advised to maintain social distancing. The advancement in clinical diagnosis techniques like Real-Time PCR (RT-PCR), immunological, microscopy, and geographic information system (GIS) mapping technology helped in tacking the rapid diagnosis and tracking viral infection in a short period. In the same way, artificial intelligence (AI), combinatorial chemistry, and deep learning approaches help to find novel therapeutics in less time and wide applicability in biomedical research. National Institute of Allergy and Infectious Diseases (NIAID) has started the clinical trials of investigation COVID-19 vaccine. Therefore, we can expect vaccines to be available for this deadly disease in the coming few months.https://www.aimspress.com/article/10.3934/microbiol.2020013/fulltext.htmlcovid-19therapeuticvaccinepandemictransmissionoutbreaksars-cov-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dharmender Kumar Lalit Batra Mohammad Tariq Malik |
spellingShingle |
Dharmender Kumar Lalit Batra Mohammad Tariq Malik Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment AIMS Microbiology covid-19 therapeutic vaccine pandemic transmission outbreak sars-cov-2 |
author_facet |
Dharmender Kumar Lalit Batra Mohammad Tariq Malik |
author_sort |
Dharmender Kumar |
title |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment |
title_short |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment |
title_full |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment |
title_fullStr |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment |
title_full_unstemmed |
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment |
title_sort |
insights of novel coronavirus (sars-cov-2) disease outbreak, management and treatment |
publisher |
AIMS Press |
series |
AIMS Microbiology |
issn |
2471-1888 |
publishDate |
2020-09-01 |
description |
Emerging and re-emerging viral diseases poses a threat to living organisms, and led to serious concern to humankind and public health. The last two decades, viral epidemics such as the severe acute respiratory syndrome(SARS-CoV) reported in the years 2002–2003, and H1N1 influenza (Swine flu) in 2009, middle east respiratory syndrome (MERS-CoV) from Saudi Arabia in 2012, Ebola virus in 2014–2016, and Zika virus in 2015. The recent outbreak of 2019-CoV-2 or severe acute respiratory syndrome-2(SARS-CoV-2), novel coronavirus (2019-nCoV, or 2019 disease, COVID-19) in Dec 2019, from, Wuhan city of China, has severe implications of health concerns to the whole world, due to global spread and high health risk. More than 423349 deaths had occurred globally and is still increasing every day. The whole world is under a health emergency, and people are advised to stay at their homes to avoid the spread of person-to-person infection, and advised to maintain social distancing. The advancement in clinical diagnosis techniques like Real-Time PCR (RT-PCR), immunological, microscopy, and geographic information system (GIS) mapping technology helped in tacking the rapid diagnosis and tracking viral infection in a short period. In the same way, artificial intelligence (AI), combinatorial chemistry, and deep learning approaches help to find novel therapeutics in less time and wide applicability in biomedical research. National Institute of Allergy and Infectious Diseases (NIAID) has started the clinical trials of investigation COVID-19 vaccine. Therefore, we can expect vaccines to be available for this deadly disease in the coming few months. |
topic |
covid-19 therapeutic vaccine pandemic transmission outbreak sars-cov-2 |
url |
https://www.aimspress.com/article/10.3934/microbiol.2020013/fulltext.html |
work_keys_str_mv |
AT dharmenderkumar insightsofnovelcoronavirussarscov2diseaseoutbreakmanagementandtreatment AT lalitbatra insightsofnovelcoronavirussarscov2diseaseoutbreakmanagementandtreatment AT mohammadtariqmalik insightsofnovelcoronavirussarscov2diseaseoutbreakmanagementandtreatment |
_version_ |
1724533722483523584 |